Accrued and other current liabilities consist of the following:
September 30,2026
December 31,2025
Compensation expense
$
7,946
9,716
Manufacturing and other research and development services
6,909
3,774
Clinical trial research and development services
5,268
5,335
General and administrative services
160
393
Other
70
80
20,353
19,298
Accrued expenses and other current liabilities.
No definition available.